ZYNROSBI
"ZYNROSBI" is a trademark owned by Nuvalent, Inc., filed at the WIPO on March 10, 2026. It is on file and covers class 5 (Pharmaceuticals).
- Status
- Mixed
- Filed
- March 10, 2026
- Registered
- Not yet
- Expires
- March 10, 2036
- Application no.
- Not recorded
- Registration no.
- 1911593
- Office
- WIPO
- World Intellectual Property Organization
- Mark type
- Trademark
- 1 class
Who owns ZYNROSBI
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Nuvalent, Inc.
NUVL · United States
Representative
Joshua S. Jarvis Foley Hoag LLP
Joshua S. Jarvis Foley Hoag LLP
What the mark covers
The products and services ZYNROSBI is filed for, grouped by Nice class.
Pharmaceutical preparations and pharmaceutical products for use in oncology diseases and disorders.
About ZYNROSBI
Who owns the trademark "ZYNROSBI"?
The WIPO trademark "ZYNROSBI" is owned by Nuvalent, Inc.
What is the status of "ZYNROSBI"?
Its status at the WIPO is: mixed.
Get this data via the API
Everything on this page comes from the Signa API. Pull ZYNROSBI and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_d0fed8ec-1d18-4fa5-bed7-6fab9ec0b74f
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_d0fed8ec-1d18-4fa5-bed7-6fab9ec0b74f",
"object": "trademark",
"mark_text": "ZYNROSBI",
"status": {
"primary": "mixed",
"stage": "mixed"
},
"office_code": "WO",
"application_number": null,
"filing_date": "2026-03-10",
"nice_classes": [
5
],
"owners": [
{
"name": "NUVALENT, INC.",
"entity_id": "ent_019eb709-fd09-76e9-8133-f6d58849ff02"
}
]
}